Age-related changes in adenosine and beta-adrenoceptor responsiveness of vascular smooth muscle in man
- PMID: 1311596
- PMCID: PMC1381203
- DOI: 10.1111/j.1365-2125.1992.tb04004.x
Age-related changes in adenosine and beta-adrenoceptor responsiveness of vascular smooth muscle in man
Abstract
1. Ageing is associated with a decline in beta-adrenergic responsiveness in several tissues. Reduced beta-adrenoceptor mediated smooth muscle relaxation in aged man has been demonstrated using the dorsal hand vein technique. Isoprenaline and adenosine activate adenylate cyclase through separate membrane bound receptors to induce vasodilatation. 2. To determine the specificity of reduced beta-adrenergic responsiveness in smooth muscle of aged man, and possible sites of the defect responsible, venodilatory responses to isoprenaline, a beta-adrenoceptor agonist and adenosine were determined in nine young (age 26 +/- 3 years: mean +/- s.d.) and eight elderly (age 70 +/- 5 years), healthy male volunteers. Veins were partially constricted with the alpha 1-adrenoceptor agonist phenylephrine and increasing doses of adenosine (5 to 1220 micrograms min-1) or isoprenaline (271 ng min-1) were infused. 3. Maximal dilatation induced by isoprenaline was 83 +/- 26% in the young and 51 +/- 34% in the elderly, P = 0.02. Maximal dilatation induced at the highest dose of adenosine (1220 micrograms min-1) was similar in young and elderly: 79 +/- 25% vs 88 +/- 28%, P = 0.26. 4. Adenosine venodilatation was measured before and after infusions of theophylline (6.8 to 135 micrograms min-1) for 30 min in six subjects. Adenosine responsiveness was unchanged following theophylline: 48 +/- 16% to 49 +/- 40%, P = 0.44. 5. The results suggest that the age-associated reduced responsiveness of the beta-adrenergic system in human vascular smooth muscle is not shared by venodilatation mediated by adenosine.
Similar articles
-
Comparison of age-related changes in prostaglandin E1 and beta-adrenergic responsiveness of vascular smooth muscle in adult males.J Gerontol. 1989 Jan;44(1):M13-7. doi: 10.1093/geronj/44.1.m13. J Gerontol. 1989. PMID: 2536054
-
Comparison of the effects of nadolol and bisoprolol on the isoprenaline-evoked dilatation of the dorsal hand vein in man.Br J Clin Pharmacol. 2001 Jun;51(6):583-9. doi: 10.1046/j.0306-5251.2001.01404.x. Br J Clin Pharmacol. 2001. PMID: 11422018 Free PMC article. Clinical Trial.
-
Responsiveness of superficial hand veins to adrenergic stimuli in patients with cystic fibrosis.Clin Sci (Lond). 1989 Mar;76(3):283-7. doi: 10.1042/cs0760283. Clin Sci (Lond). 1989. PMID: 2924520
-
Decline in beta adrenergic receptor-mediated vascular relaxation with aging in man.J Pharmacol Exp Ther. 1986 Dec;239(3):802-7. J Pharmacol Exp Ther. 1986. PMID: 3025419
-
Beta-adrenoceptor responsiveness in hypertension: effects of dietary NaCl intake.Br J Clin Pharmacol. 1990;30 Suppl 1(Suppl 1):55S-60S. doi: 10.1111/j.1365-2125.1990.tb05469.x. Br J Clin Pharmacol. 1990. PMID: 2176530 Free PMC article. Review.
Cited by
-
Pinpointing beta adrenergic receptor in ageing pathophysiology: victim or executioner? Evidence from crime scenes.Immun Ageing. 2013 Mar 15;10(1):10. doi: 10.1186/1742-4933-10-10. Immun Ageing. 2013. PMID: 23497413 Free PMC article.
-
A role for cyclooxygenase in aging-related changes of beta-adrenoceptor-mediated relaxation in rat aortas.Naunyn Schmiedebergs Arch Pharmacol. 2007 Jun;375(4):273-81. doi: 10.1007/s00210-007-0153-y. Epub 2007 Apr 3. Naunyn Schmiedebergs Arch Pharmacol. 2007. PMID: 17404710
-
Nitric oxide mediated venodilator effects of nebivolol.Br J Clin Pharmacol. 1994 Sep;38(3):199-204. doi: 10.1111/j.1365-2125.1994.tb04342.x. Br J Clin Pharmacol. 1994. PMID: 7826820 Free PMC article. Clinical Trial.
-
Clinical pharmacology, physiology and pathophysiology of superficial veins--2.Br J Clin Pharmacol. 1994 Oct;38(4):289-305. doi: 10.1111/j.1365-2125.1994.tb04357.x. Br J Clin Pharmacol. 1994. PMID: 7833218 Free PMC article. Review. No abstract available.
-
Pharmacokinetic and pharmacodynamic changes in the elderly. Clinical implications.Clin Pharmacokinet. 1998 Jul;35(1):49-64. doi: 10.2165/00003088-199835010-00004. Clin Pharmacokinet. 1998. PMID: 9673834 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous